A Single-center, Prospective, Randomized, Parallel Group, Placebo-controlled Exploratory Study on the Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy

Trial Profile

A Single-center, Prospective, Randomized, Parallel Group, Placebo-controlled Exploratory Study on the Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy

Discontinued
Phase of Trial: Phase III

Latest Information Update: 31 May 2017

At a glance

  • Drugs Cilostazol/ginkgo biloba (Primary)
  • Indications Ear disorders
  • Focus Registrational; Therapeutic Use
  • Acronyms REREV
  • Most Recent Events

    • 19 Feb 2016 Last checked against ClinicalTrials.gov record.
    • 14 Feb 2016 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 04 Jan 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top